Education
About Us
Working with TipRanks
Follow Us
Tom Frohlich Insider Profile
4 Followers
Tom Frohlich, COO at Chinook Therapeutics, holds 6.00K shares in Jade Biosciences (Ticker: JBIO), holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY). Most recently, Tom Frohlich Bought ― shares of Jade Biosciences on May 19, 2025 for an estimated value of 44.40K.
Tom Frohlich Chinook Therapeutics (KDNY)COO
Chinook Therapeutics (KDNY)
COO
Not Ranked
Tom Frohlich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Executive Officer, Director
Roles that Tom Frohlich holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Tom Frohlich
Tom Frohlich's Trading History
Chinook Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
Jade Biosciences
May 19, 2025
Chief Executive Officer, Director
Informative Buy
44.40K
$44.52K
List of latest transactions for each holding click on a transaction to see Tom Frohlich's performance on stock
You May Also Like
Tom Frohlich insider profile FAQ
What is the percentage of profitable transactions made by Tom Frohlich?
The percentage of profitable transactions made by Tom Frohlich is ―.
What is the average return per transaction made by Tom Frohlich?
The average return per transaction made by Tom Frohlich is ―.
What stocks does Tom Frohlich hold?
Tom Frohlich holds: KDNY, JBIO stocks.
What was Tom Frohlich’s latest transaction?
Tom Frohlich latest transaction was an Informative Buy of $44.40K.
What was Tom Frohlich's most profitable transaction?
Tom Frohlich’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Tom Frohlich's role in Chinook Therapeutics?
Tom Frohlich's role in Chinook Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.